clinical trial · NCT00545324
First Step With Singulair® Therapy (0476-323)
Organon and Co·phase4·completed·n = 399
AsthmaMK0476 (singulair), montelukast sodium / Duration of Treatment: 6 WeeksComparator: Fluticasone / Duration of Treatment: 6 Weeks
brief summary
In adult patients with mild persistent asthma, singulair® 10 mg will be at least as effective as low dose Inhaled Corticosteroids (ICS) in improving asthma symptom control or satisfaction over a 6 week comparison period.
started
Sep 1, 2002
primary completion
Dec 1, 2003
completion
Dec 1, 2003
last updated
Aug 15, 2024
official title
A 12 Week Multicenter, Open-Label, Randomized, Observational Study Comparing Singulair® 10 Mg As Controller Monotherapy In Adults With Mild Asthma "To Low Dose" Inhaled Corticosteroid Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol